Catalent Inc (NYSE:CTLT)
| 52.60 Delayed Data As of Jan 30 |  +0.02 / +0.04%Today’s Change | 40.69 Today|||52-Week Range 115.34 | +16.86% Year-to-Date |
Latest CTLT News | Press Releases
| Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates Jan 24 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 52.58 |
| Today’s open | 52.73 |
| Day’s range | 52.59 - 54.36 |
| Volume | 2,865,116 |
| Average volume (3 months) | 2,849,422 |
| Market cap | $9.7B |
Data as of 3:59pm ET, 01/30/2023
Growth & Valuation
| Earnings growth (last year) | -9.24% |
| Earnings growth (this year) | -15.94% |
| Earnings growth (next 5 years) | +4.95% |
| Revenue growth (last year) | +20.76% |
| P/E ratio | 22.4 |
| Price/Sales | 3.96 |
| Price/Book | 2.01 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JAZZJazz Pharmaceuticals... | -1.76 | -1.13% |
| RGENRepligen Corp | -14.88 | -7.63% |
| RDYDr Reddy's Laborator... | +0.18 | +0.34% |
| SRPTSarepta Therapeutics... | -2.04 | -1.66% |
Data as of 4:00pm ET, 01/30/2023
Financials
| Next reporting date | February 7, 2023 |
| EPS forecast (this quarter) | $0.69 |
| Annual revenue (last year) | $4.8B |
| Annual profit (last year) | $503.0M |
| Net profit margin | 10.42% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Somerset, New Jersey |
Forecasts
